Marine Natural Products for Cancer Therapy: From Molecular Mechanisms to Clinical Translation
Marine Drugs · 10.11.2026 · 24 (11) · 403
DOI: 10.3390/md24110403 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 10.11.2026. Verfasst von Ziqi Zhu und 7 weiteren Autor:innen. Die Arbeit nennt 162 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National College Students’ Innovative Entrepreneurial Training Plan Program.
Abstract (Originalsprache)
Cancer continues to impose a major global health burden. Conventional therapies often show poor selectivity, off-target toxicity, and drug resistance, creating an urgent need for new agents. The marine environment covers roughly 71% of Earth’s surface and has fostered metabolites of unparalleled chemical diversity, making the ocean a vital source for anticancer drug discovery. This review critically examines the published literature on six representative marine-derived agents—cytarabine, trabectedin, eribulin, brentuximab vedotin, carrageenan, and Aspergillus fumigatus alkaloids. We compare their biological sources, anti-tumor spectra, molecular targets, and oncogenic pathways, and we analyze the structure—activity relationships and the total, semi-, and engineered synthesis routes that underpin their optimization. We also appraise the major barriers to clinical translation—sustainable supply, mechanistic ambiguity, and suboptimal druggability—alongside emerging solutions based on synthetic biology, multi-omics, artificial intelligence, and advanced formulation. Marine-derived agents therefore represent a chemically distinctive and mechanistically diverse reservoir for targeted cancer therapy. Realizing this potential will require structure—activity-guided optimization, secure synthetic or engineered supply, and biomarker-informed combination strategies that still await prospective validation.
Förderung
- National Natural Science Foundation of China
- National College Students’ Innovative Entrepreneurial Training Plan Program
Zitieren
APA
Zhu, Z., Xie, X., Meng, W., Fang, K., Deng, J., Yan, Y., Wei, J., & Zhou, L. (2026). Marine Natural Products for Cancer Therapy: From Molecular Mechanisms to Clinical Translation. Marine Drugs, 24(11), 403. https://doi.org/10.3390/md24110403
Vancouver
Zhu Z, Xie X, Meng W, Fang K, Deng J, Yan Y, et al. Marine Natural Products for Cancer Therapy: From Molecular Mechanisms to Clinical Translation. Marine Drugs. 2026;24(11):403. doi:10.3390/md24110403
BibTeX
@article{Zhu2026,
author = {Zhu, Ziqi and Xie, Xinyi and Meng, Weijia and Fang, Kenuo and Deng, Jiahui and Yan, Yusi and Wei, Jundong and Zhou, Lisha},
title = {Marine Natural Products for Cancer Therapy: From Molecular Mechanisms to Clinical Translation},
journal = {Marine Drugs},
year = {2026},
volume = {24},
number = {11},
pages = {403},
doi = {10.3390/md24110403}
}
EUVIMED